Fluoroquinolone resistance among fecal extended spectrum βeta lactamases positive Enterobacterales isolates from children in Dar es Salaam, Tanzania (Record no. 28064)

MARC details
000 -LEADER
fixed length control field 03711nam a22003497a 4500
001 - CONTROL NUMBER
control field 20240611151504.0
003 - CONTROL NUMBER IDENTIFIER
control field 20240611151504.0
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240611152126.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240611b |||||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1471-2334
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
100 ## - MAIN ENTRY--PERSONAL NAME
Fuller form of name Upendo O. Kibwana
245 ## - TITLE STATEMENT
Title Fluoroquinolone resistance among fecal extended spectrum βeta lactamases positive Enterobacterales isolates from children in Dar es Salaam, Tanzania
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mwanza, Tanzania :
Name of publisher, distributor, etc. Catholic University of Health and Allied Sciences [CUHAS-Bugando] :
Date of publication, distribution, etc. 2023
300 ## - PHYSICAL DESCRIPTION
Extent Pages 01-13
Extent Includes References
490 ## - SERIES STATEMENT
Volume/sequential designation BMC Infectious Diseases volume 23, Article number: 135 (2023)
520 ## - SUMMARY, ETC.
Summary, etc. Abstract :<br/><br/>Background : Fluoroquinolones have been, and continue to be, routinely used for treatment of many bacterial infections. In recent years, most parts of the world have reported an increasing trend of fluoroquinolone resistant (FQR) Gram-negative bacteria.<br/><br/>Methods : A cross-sectional study was conducted between March 2017 and July 2018 among children admitted due to fever to referral hospitals in Dar es Salaam, Tanzania. Rectal swabs were used to screen for carriage of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE). ESBL-PE isolates were tested for quinolone resistance by disk diffusion method. Randomly selected fluroquinolone resistant isolates were characterized by using whole genome sequencing.<br/><br/>Results : A total of 142 ESBL-PE archived isolates were tested for fluoroquinolone resistance. Overall phenotypic resistance to ciprofloxacin, levofloxacin and moxifloxacin was found in 68% (97/142). The highest resistance rate was seen among Citrobacter spp. (100%, 5/5), followed by Klebsiella. pneumoniae (76.1%; 35/46), Escherichia coli (65.6%; 42/64) and Enterobacter spp. (31.9%; 15/47). Whole genome sequencing (WGS) was performed on 42 fluoroquinolone resistant-ESBL producing isolates and revealed that 38/42; or 90.5%, of the isolates carried one or more plasmid mediated quinolone resistance (PMQR) genes. The most frequent PMQR genes were aac(6’)-lb-cr (74%; 31/42), followed by qnrB1 (40%; 17/42), oqx, qnrB6 and qnS1. Chromosomal mutations in gyrA, parC and parE were detected among 19/42 isolates, and all were in E. coli. Most of the E. coli isolates (17/20) had high MIC values of > 32 µg/ml for fluoroquinolones. In these strains, multiple chromosomal mutations were detected, and all except three strains had additional PMQR genes. Sequence types, ST131 and ST617 predominated among E. coli isolates, while ST607 was more common out of 12 sequence types detected among the K. pneumoniae. Fluoroquinolone resistance genes were mostly associated with the IncF plasmids.<br/><br/>Conclusion : The ESBL-PE isolates showed high rates of phenotypic resistance towards fluoroquinolones likely mediated by both chromosomal mutations and PMQR genes. Chromosomal mutations with or without the presence of PMQR were associated with high MIC values in these bacteria strains. We also found a diversity of PMQR genes, sequence types, virulence genes, and plasmid located antimicrobial resistance (AMR) genes towards other antimicrobial agents.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision ESBL-PE
General subdivision Fluoroquinolone resistance
General subdivision Whole genome sequencing
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Joel Manyahi
Fuller form of name Helene Heitmann Sandnes
Fuller form of name Bjørn Blomberg
Fuller form of name Stephen E. Mshana
Fuller form of name Nina Langeland
Fuller form of name Adam P. Roberts
Fuller form of name Sabrina J. Moyo
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1186/s12879-023-08086-2">https://doi.org/10.1186/s12879-023-08086-2</a>
Link text https://doi.org/10.1186/s12879-023-08086-2
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type RESEARCH ARTICLES
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 06/11/2024   20240611151504.0 06/11/2024 06/11/2024 RESEARCH ARTICLES
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024